glp 1 for alcohol GLP-1 RAs may reduce alcohol-related hospitalization risk GLP-1 Receptor Agonists: Promising Therapeutic

Purpose-built for physicians GLP-1RA use linked to lower risk for cirrhosis, mortality in MASLD with diabetes Key takeaways: Glucagon-like peptide-1 receptor agonist use was associated with a lower risk for progression to cirrhosis, its complications and mortality

Castaneda C, Marsden K, Maxwell T, Ten Eyck P, Kuwaye D, Kenne KA, et al

10.1016/S0140-6736(09)61307-6 140 PykeC.KnudsenL

10.1016/j.chom.2013.09.012 114 WongC

Contact your healthcare provider if you experience minimal improvement after reaching maintenance dose for 12-16 weeks, including persistently elevated blood glucose or lack of at least 5% body weight reduction

When you hear about compounded semaglutide, it means a compounded medication that may use semaglutide as an ingredient